Keith R Solomon

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Ezetimibe is an inhibitor of tumor angiogenesis
    Keith R Solomon
    Dept of Orthopaedic Surgery, Harvard Medical School, Boston, MA 02115, USA
    Am J Pathol 174:1017-26. 2009
  2. ncbi The complex interplay between cholesterol and prostate malignancy
    Keith R Solomon
    The Urological Diseases Research Center, Children s Hospital Boston, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA
    Urol Clin North Am 38:243-59. 2011
  3. ncbi Do the cholesterol-lowering properties of statins affect cancer risk?
    Keith R Solomon
    Department of Orthopaedic Surgery, Children s Hospital Boston, Boston, MA 02115, USA
    Trends Endocrinol Metab 19:113-21. 2008
  4. ncbi Cholesterol sensitivity of endogenous and myristoylated Akt
    Rosalyn M Adam
    Urological Diseases Research Center, Children s Hospital Boston, Boston, Massachusetts 02115, USA
    Cancer Res 67:6238-46. 2007
  5. ncbi Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts
    Liyan Zhuang
    The Urological Diseases Research Center, Department of Urology, Children's Hospital Boston, Boston, Massachusetts 02115, USA
    J Clin Invest 115:959-68. 2005
  6. ncbi Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase
    Dolores Di Vizio
    The Urological Diseases Research Center and Department of Surgery, Children s Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA
    Cell Cycle 7:2257-67. 2008
  7. ncbi Cholesterol and benign prostate disease
    Michael R Freeman
    The Urological Diseases Research Center, Children s Hospital Boston, Enders Research Laboratories, 300 Longwood Ave, Boston, MA 02115, USA
    Differentiation 82:244-52. 2011
  8. ncbi Cholesterol and cholesterol-rich membranes in prostate cancer: an update
    Dolores Di Vizio
    The Urological Diseases Research Center, Department of Urology, Children s Hospital Boston, Harvard Medical School, Boston, MA 02115, USA
    Tumori 94:633-9. 2008
  9. ncbi Transit of hormonal and EGF receptor-dependent signals through cholesterol-rich membranes
    Michael R Freeman
    Urological Diseases Research Center, Department of Urology, Children s Hospital Boston, Boston, MA 02115, United States
    Steroids 72:210-7. 2007
  10. ncbi Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells
    Jayoung Kim
    The Urologic Laboratory, John F. Enders Research Laboratories, Room 1161, Children's Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA
    Endocrinology 145:613-9. 2004

Collaborators

Detail Information

Publications26

  1. ncbi Ezetimibe is an inhibitor of tumor angiogenesis
    Keith R Solomon
    Dept of Orthopaedic Surgery, Harvard Medical School, Boston, MA 02115, USA
    Am J Pathol 174:1017-26. 2009
    ....
  2. ncbi The complex interplay between cholesterol and prostate malignancy
    Keith R Solomon
    The Urological Diseases Research Center, Children s Hospital Boston, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA
    Urol Clin North Am 38:243-59. 2011
    ..The data strongly point to hypercholesterolemia as a risk factor for prostate cancer progression and suggest clinical opportunities for the use of cholesterol-lowering therapies to alter disease course...
  3. ncbi Do the cholesterol-lowering properties of statins affect cancer risk?
    Keith R Solomon
    Department of Orthopaedic Surgery, Children s Hospital Boston, Boston, MA 02115, USA
    Trends Endocrinol Metab 19:113-21. 2008
    ..Our hypothesis provides a perspective from which mechanistic studies of cholesterol-lowering drugs and cancer, in addition to prospective trials in patients, might be designed...
  4. ncbi Cholesterol sensitivity of endogenous and myristoylated Akt
    Rosalyn M Adam
    Urological Diseases Research Center, Children s Hospital Boston, Boston, Massachusetts 02115, USA
    Cancer Res 67:6238-46. 2007
    ....
  5. ncbi Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts
    Liyan Zhuang
    The Urological Diseases Research Center, Department of Urology, Children's Hospital Boston, Boston, Massachusetts 02115, USA
    J Clin Invest 115:959-68. 2005
    ..Our results implicate membrane cholesterol in Akt signaling in both normal and malignant cells and provide evidence that PCa cells can become dependent on a cholesterol-regulated Akt pathway for cell survival...
  6. ncbi Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase
    Dolores Di Vizio
    The Urological Diseases Research Center and Department of Surgery, Children s Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA
    Cell Cycle 7:2257-67. 2008
    ..These findings suggest that FASN and Cav-1 physically and functionally interact in PCa cells. They also imply that palmitoylation within this complex is involved in tumor growth and survival...
  7. ncbi Cholesterol and benign prostate disease
    Michael R Freeman
    The Urological Diseases Research Center, Children s Hospital Boston, Enders Research Laboratories, 300 Longwood Ave, Boston, MA 02115, USA
    Differentiation 82:244-52. 2011
    ..Here we review the evidence that cholesterol metabolism plays a role in the incidence of benign prostate disease and we highlight possible therapeutic approaches based on this concept...
  8. ncbi Cholesterol and cholesterol-rich membranes in prostate cancer: an update
    Dolores Di Vizio
    The Urological Diseases Research Center, Department of Urology, Children s Hospital Boston, Harvard Medical School, Boston, MA 02115, USA
    Tumori 94:633-9. 2008
    ..This hypothesis provides new avenues for mechanistic studies as well as therapeutic intervention...
  9. ncbi Transit of hormonal and EGF receptor-dependent signals through cholesterol-rich membranes
    Michael R Freeman
    Urological Diseases Research Center, Department of Urology, Children s Hospital Boston, Boston, MA 02115, United States
    Steroids 72:210-7. 2007
    ..Understanding the manner in which these pathways converge within cholesterol-rich membranes may present new avenues for therapeutic intervention in hormone-dependent cancers...
  10. ncbi Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells
    Jayoung Kim
    The Urologic Laboratory, John F. Enders Research Laboratories, Room 1161, Children's Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA
    Endocrinology 145:613-9. 2004
    ..Our results also suggest a mechanistic role for membrane cholesterol in cell signaling events relevant to PCa progression...
  11. ncbi Ezetimibe reduces enlarged prostate in an animal model of benign prostatic hyperplasia
    Kristine Pelton
    Department of Orthopaedic Surgery, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Urol 184:1555-9. 2010
    ..We report that the Bio 87.20 hamster strain (Bio Breeders, Watertown, Massachusetts) shows 5?-reductase-sensitive prostate enlargement and a decrease in circulating cholesterol reduces prostate size...
  12. ncbi Cholesterol-regulated stress fiber formation
    Maosong Qi
    Department of Orthopaedic Surgery, Harvard Medical School, 300 Longwood Avenue, Boston, Massachusetts 02115, USA
    J Cell Biochem 106:1031-40. 2009
    ..These results demonstrate that cholesterol is a critical regulator of membrane-cytoskeletal dynamics and suggest that altered cholesterol concentrations may result in dramatic changes in cellular responses mediated by the cytoskeleton...
  13. ncbi Two different PDGF beta-receptor cohorts in human pericytes mediate distinct biological endpoints
    Christian Sundberg
    Department of Orthopaedic Surgery, Children s Hospital, Boston, Massachusetts 02115, USA
    Am J Pathol 175:171-89. 2009
    ..Thus, growth factor receptors are segregated into specific cell membrane compartments that are preferentially activated through different mechanisms of ligand delivery, resulting in distinct biological endpoints...
  14. ncbi The role of cholesterol in prostate cancer
    Martin H Hager
    The Urological Diseases Research Center, Department of Urology, Children's Hospital Boston, Massachusetts 02115, USA
    Curr Opin Clin Nutr Metab Care 9:379-85. 2006
    ..The identification of cholesterol as a critical component in signal transduction events in prostate cancer cells has not only provided new mechanistic insights but also opened up new avenues for chemotherapeutic intervention...
  15. ncbi A quantitative proteomic analysis of growth factor-induced compositional changes in lipid rafts of human smooth muscle cells
    Dawn L MacLellan
    Department of Urology, The Urological Diseases Research Center, Boston, MA, USA
    Proteomics 5:4733-42. 2005
    ..In addition, eight Rho family members were localized to rafts by ICAT analysis. Collectively, these observations suggest a role for lipid rafts in regulation of PDGF-stimulated changes in the cytoskeleton...
  16. ncbi Prohibitin is a cholesterol-sensitive regulator of cell cycle transit
    Pei Dong
    Department of Orthopaedic Surgery, Children s Hospital Boston, 300 Longwood Avenue, Boston, Massachusetts 02115, USA
    J Cell Biochem 111:1367-74. 2010
    ..We also demonstrate that prohibitin protects cells from apoptosis caused by cholesterol insufficiency. This is the first study tying cholesterol homeostasis to a specific cell cycle regulator that inhibits apoptosis...
  17. ncbi Cholesterol and prostate cancer
    Michael R Freeman
    The Urological Diseases Research Center, Children s Hospital Boston, Boston, Massachusetts 02115, USA
    J Cell Biochem 91:54-69. 2004
    ....
  18. ncbi HMG-CoA reductase inhibitors induce apoptosis in pericytes
    Kelly Boucher
    Department Orthopaedic Surgery, Children's Hospital Boston, Boston, MA 02115, USA
    Microvasc Res 71:91-102. 2006
    ....
  19. ncbi Caveolin-1alpha and -1beta perform nonredundant roles in early vertebrate development
    Ping Ke Fang
    Urological Diseases Research Center, Department of Orthopaedic Surgery, Children s Hospital Boston, Harvard Medical School, Enders Research Laboratories, Suite 1161, 300 Longwood Ave, Boston, MA 02115, USA
    Am J Pathol 169:2209-22. 2006
    ..Cav-1alpha and -1beta morphants also exhibited disruption in the actin cytoskeleton. These results support important and previously unanticipated roles for the Caveolin-1 isoforms in vertebrate organogenesis...
  20. ncbi High-throughput tool for discovery of bone regulating factors
    Parul Sharma
    Childrens Hospital Boston, Boston, MA 02115, USA
    Biotechniques 41:539-40, 542. 2006
  21. ncbi Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells
    Liyan Zhuang
    The Urologic Laboratory, Department of Urology, Harvard Medical School, Boston, MA 02115, USA
    Cancer Res 62:2227-31. 2002
    ..These results suggest that cholesterol present in membrane microdomains is a prominent mediator of survival in prostate cancer cells...
  22. ncbi CD109 represents a novel branch of the alpha2-macroglobulin/complement gene family
    Keith R Solomon
    Department of Orthopaedic Surgery, Children s Hospital, Boston, MA 02115, USA
    Gene 327:171-83. 2004
    ..elegans (ZK337.1) and E. coli homologs, we propose CD109 represents a novel and independent branch of the alpha2-macroglobulin/complement gene family (AMCOM) and may be its oldest member...
  23. ncbi Toxicity of human pharmaceuticals and personal care products to benthic invertebrates
    Eve B Dussault
    Department of Environmental Biology, University of Guelph, Guelph, ON, Canada
    Environ Toxicol Chem 27:425-32. 2008
    ..In contrast, our data also indicate that considering the low concentrations currently detected in the environment, ATO and EE(2) pose negligible risks to benthic invertebrates...
  24. ncbi Statins and the risk of cancer
    Michael R Freeman
    JAMA 295:2720-1; author reply 2721-2. 2006
  25. ncbi Platelet derived growth factor-BB is a potent mitogen for rat ureteral and human bladder smooth muscle cells: dependence on lipid rafts for cell signaling
    Maximilain Stehr
    J Urol 169:1165-70. 2003
    ....
  26. ncbi Role of temperature and enzyme induction in the biotransformation of polychlorinated biphenyls and bioformation of hydroxylated polychlorinated biphenyls by rainbow trout (Oncorhynchus mykiss)
    Andrea H Buckman
    Department of Environmental Biology, University of Guelph, Guelph, ON, Canada N1G 2W1
    Environ Sci Technol 41:3856-63. 2007
    ..The results of this study provide the first in vivo evidence that rainbow trout are responsive to CYP2B-like induction by PCBs and that this enzyme system can influence PCB concentrations and OH-PCB formation in fish...